Aslan Fredinsider trades
In SEC Form 4 filings, Aslan Fred is listed as Chief Executive Officer of Artiva Biotherapeutics, Inc. (ARTV). In the last 90 days, Aslan Fred sold $1.54M of Artiva Biotherapeutics, Inc. (ARTV) on the open market and bought none. 2 of the 4 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ARTVArtiva Biotherapeutics, Inc. | Chief Executive Officer | 8 | Oct 7 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-04
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ARTVArtiva Biotherapeutics, Inc. | Oct 6 | Oct 7 | S | 23,463 | $7.20 | Sale −$168,880 | 1,519,606 | Yes | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Oct 5 | Oct 6 | S | 61,696 | $6.84 | Sale −$421,828 | 1,543,069 | No | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Sep 15 | Sep 15 | A | 110,000 | $0.00 | $0 | 1,604,765 | No | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Sep 15 | Sep 15 | A · derivative | 315,000 | $8.91 | $2,806,650 | 315,000 | No | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Sep 10 | Sep 14 | A | 45,000 | $0.00 | $0 | 1,494,765 | No | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Sep 10 | Sep 14 | A · derivative | 155,000 | $10.42 | $1,615,100 | 155,000 | No | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Sep 8 | Sep 9 | S | 23,429 | $10.92 | Sale −$255,746 | 1,449,765 | Yes | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Sep 3 | Sep 4 | S | 61,888 | $11.16 | Sale −$690,392 | 1,473,194 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.